Walleye Trading LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Walleye Trading LLC

$46 Billion
Q4 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $92,508 - $160,472	-5,200 Reduced 28.57%	13,000 $240,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $37,404 - $57,186	1,800 Added 10.98%	18,200 $569,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $77,108 - $123,839	3,700 Added 29.13%	16,400 $341,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $176,256 - $225,936	10,800 Added 568.42%	12,700 $239,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $22,720 - $29,808	1,600 Added 533.33%	1,900 $30,000
Q2 2022 Aug 08, 2022	SELL	$13.01 - $27.22 $70,254 - $146,988	-5,400 Reduced 94.74%	300 $4,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $167,520 - $220,000	-8,000 Reduced 58.39%	5,700 $138,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $67,160 - $108,360	-4,000 Reduced 22.6%	13,700 $320,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $149,910 - $235,315	9,500 Added 115.85%	17,700 $294,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $159,080 - $224,844	8,200 New	8,200 $200,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $4.11 Million - $6.08 Million	-129,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $4.36 Million - $6.19 Million	120,400 Added 1294.62%	129,700 $5.55 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $1.42 Million - $2.81 Million	-63,900 Reduced 87.3%	9,300 $335,000
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $1.71 Million - $2.06 Million	73,200 New	73,200 $1.96 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $153,615 - $260,110	-9,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $134,608 - $215,448	9,400 Added 9400.0%	9,500 $154,000
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $1,303 - $2,181	100 New	100 $2,000
Q3 2017 Nov 14, 2017	SELL	$29.49 - $38.37 $2,949 - $3,836	-100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $3,000

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.18B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account